Sentinel Node Biopsy for Breast Cancer: Technical Aspects and Controversies

  • Motomura Kazuyoshi
    Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Egawa Chiyomi
    Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Komoike Yoshifumi
    Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Kataoka Tatsuki
    Departments of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Nagumo Sachiko
    Departments of Cytology, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Koyama Hiroki
    Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • Inaji Hideo
    Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases

Search this article

Abstract

Sentinel node biopsy has rapidly emerged as a minimally invasive, highly accurate method of axillary staging, and has replaced routine axillary lymph node dissection as the new standard of care in breast cancer. However, many practical problems remain and details of the technique have not been standardized yet. Guideline recommendations help us to perform appropriate sentinel node biopsy and pathological examination. We should perform sentinel node biopsy without deviation from such consensus guidelines.<BR>The technical controversies of sentinel node biopsy are discussed in this article and the results of our studies about sentinel node biopsy in breast cancer are reviewed.

Journal

  • Breast Cancer

    Breast Cancer 14 (1), 25-30, 2007

    The Japanese Breast Cancer Society

Citations (3)*help

See more

References(36)*help

See more

Details 詳細情報について

Report a problem

Back to top